214 related articles for article (PubMed ID: 10447932)
21. Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma.
Antonia SJ; Seigne J; Diaz J; Muro-Cacho C; Extermann M; Farmelo MJ; Friberg M; Alsarraj M; Mahany JJ; Pow-Sang J; Cantor A; Janssen W
J Urol; 2002 May; 167(5):1995-2000. PubMed ID: 11956426
[TBL] [Abstract][Full Text] [Related]
22. Human T-cell response to L14 pig cell line transfected with human ligands CD80 and CD86.
Millán O; Rojo I; Juan M; Vilardell C; Yagüe J; Vives J; Martorell J
Transplant Proc; 1999 Sep; 31(6):2630. PubMed ID: 10500750
[No Abstract] [Full Text] [Related]
23. Replication-deficient adenovirus-mediated transfer of B7-1 (CD80) cDNA induces anti-tumour immunity in isolated human lung cancer.
Iwakami SI; Setoguchi Y; Saijo Y; Azuma M; Fukuchi Y
Respirology; 2001 Jun; 6(2):135-44. PubMed ID: 11422893
[TBL] [Abstract][Full Text] [Related]
24. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation.
Thebeau LG; Morrison LA
J Virol; 2003 Feb; 77(4):2426-35. PubMed ID: 12551980
[TBL] [Abstract][Full Text] [Related]
26. Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours.
Chong H; Hutchinson G; Hart IR; Vile RG
Br J Cancer; 1998 Oct; 78(8):1043-50. PubMed ID: 9792148
[TBL] [Abstract][Full Text] [Related]
27. Characterization of rat CD80 and CD86 by molecular cloning and mAb.
Maeda K; Sato T; Azuma M; Yagita H; Okumura K
Int Immunol; 1997 Jul; 9(7):993-1000. PubMed ID: 9237108
[TBL] [Abstract][Full Text] [Related]
28. Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes.
Jung D; Jaeger E; Cayeux S; Blankenstein T; Hilmes C; Karbach J; Moebius U; Knuth A; Huber C; Seliger B
Hum Gene Ther; 1998 Jan; 9(1):53-62. PubMed ID: 9458242
[TBL] [Abstract][Full Text] [Related]
29. gamma-ray irradiation induces B7.1 expression in myeloid leukaemic cells.
Vereecque R; Buffenoir G; Gonzalez R; Cambier N; Hetuin D; Bauters F; Fenaux P; Quesnel B
Br J Haematol; 2000 Mar; 108(4):825-31. PubMed ID: 10792289
[TBL] [Abstract][Full Text] [Related]
30. B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.
Zheng X; Gao JX; Chang X; Wang Y; Liu Y; Wen J; Zhang H; Zhang J; Liu Y; Zheng P
J Immunol; 2004 Aug; 173(4):2253-61. PubMed ID: 15294937
[TBL] [Abstract][Full Text] [Related]
31. Effect of B7.1-transfected human colon cancer cells on the induction of autologous tumour-specific cytotoxic T cells.
Miyazono Y; Kamogawa Y; Ryo K; Furukawa T; Mitsuhashi M; Yamauchi K; Kameoka T; Hayashi N
J Gastroenterol Hepatol; 1999 Oct; 14(10):997-1003. PubMed ID: 10530496
[TBL] [Abstract][Full Text] [Related]
32. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.
Wendtner CM; Nolte A; Mangold E; Buhmann R; Maass G; Chiorini JA; Winnacker EL; Emmerich B; Kotin RM; Hallek M
Gene Ther; 1997 Jul; 4(7):726-35. PubMed ID: 9282174
[TBL] [Abstract][Full Text] [Related]
33. Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.
Kallfelz M; Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
Int J Cancer; 1999 Mar; 81(1):125-33. PubMed ID: 10077163
[TBL] [Abstract][Full Text] [Related]
34. T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector.
Döhring C; Angman L; Spagnoli G; Lanzavecchia A
Int J Cancer; 1994 Jun; 57(5):754-9. PubMed ID: 7515023
[TBL] [Abstract][Full Text] [Related]
35. Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells.
Mogi S; Sakurai J; Kohsaka T; Enomoto S; Yagita H; Okumura K; Azuma M
Immunology; 2000 Dec; 101(4):541-7. PubMed ID: 11122458
[TBL] [Abstract][Full Text] [Related]
36. Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis.
Daniel PT; Kroidl A; Cayeux S; Scholz C; Sturm I; Blankenstein T; Pezzutto A; Dörken B
Adv Exp Med Biol; 1998; 451():265-76. PubMed ID: 10026884
[No Abstract] [Full Text] [Related]
37. Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma.
Leong CC; Marley JV; Loh S; Milech N; Robinson BW; Garlepp MJ
Int J Cancer; 1997 May; 71(3):476-82. PubMed ID: 9139887
[TBL] [Abstract][Full Text] [Related]
38. Human naive and memory T-helper cells display distinct adhesion properties to ICAM-1, LFA-3 and B7 molecules.
Parra E; Wingren AG; Hedlund G; Sjögren HO; Kalland T; Sansom D; Dohlsten M
Scand J Immunol; 1993 Dec; 38(6):508-14. PubMed ID: 7504826
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA
Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727
[TBL] [Abstract][Full Text] [Related]
40. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]